- 令和
- 新型肺炎
- 記者
- ゲノム
- 中国企業
- 参加
- 建設
- 感染対策
- 華大基因
- 設計
「シーケンシング」の写真・グラフィックス・映像
- 提供元
- 日付
- 種類
- 向き
- カテゴリ
- 色
- 同義語オン
- 提供元
- 日付
- 24時間以内 0
- 48時間以内 0
- 72時間以内 0
- 7日以内 0
- 30日以内 0
- 1年以内 2
- 期間を指定 313
- 日付指定なし 313
- 種類
- 写真 301
- グラフィックス 0
- 映像 12
- 向き
- 縦 19
- 横 293
- 正方形 1
- カテゴリ
- ニュース
- スポーツ
- エンターテインメント
- 教育向け
- カテゴリ指定なし
- 色
- カラー 310
- モノクロ 3
- 同義語辞書
- 古い順
- 1
- 2
- 3
- 4
- 古い順
-a square-shaped genea square-shaped gene sequencing computer chip design、クレジット：Ｗｏｒｌｄ Ｈｉｓｔｏｒｙ Ａｒｃｈｉｖｅ／ニューズコム／共同通信イメージズ
商品コード: 2020041501839
-Colaptes rivolii, Print,Colaptes rivolii, Print, The crimson-mantled woodpecker (Colaptes rivolii) is a bird species in the woodpecker family (Picidae). It was formerly placed in the genus Piculus but moved to the genus Colaptes after mitochondrial DNA sequencing. Its scientific name, rivolii, honors French ornithologist François Victor Masséna, second Duke of Rivoli and third Prince of Essling., 1820-1860.、クレジット：Ａｌｂｕｍ／ｑｕｉｎｔｌｏｘ／共同通信イメージズ ※エディトリアル使用のみ。表紙、広告、プロモーション、商業目的での利用はお問合せください。クレジットは必ず表記してください。
商品コード: 2022122904100
-a square-shaped genea square-shaped gene sequencing computer chip design、クレジット：Ｗｏｒｌｄ Ｈｉｓｔｏｒｙ Ａｒｃｈｉｖｅ／ニューズコム／共同通信イメージズ
商品コード: 2020041501858
2015年04月23日OPED-HEALTH-WELLNESS-COMMENTARY-SLApril 23, 2015, St. Louis, MO, USA: A research technician holds up a used flow cell to display its intricacies at the Genome Institute at Washington University on Thursday, April 23, 2015. A flow cell holds the DNA for the sequencing machine. (Credit Image: © TNS via ZUMA Wire)、クレジット：©ＴＮＳ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021032412428
2019年05月23日Chancellor visits biotech company Centogene23 May 2019, Mecklenburg-Western Pomerania, Rostock: During their visit to the biotech company Centogene, German Chancellor Angela Merkel (CDU, l) and Manuela Schwesig (SPD), Minister President of Mecklenburg-Western Pomerania, will be informed about the facility by Arndt Rolfs, CEO, in the DNA sequencing laboratory. Centogene AG specializes in the diagnosis and characterization of rare congenital diseases and operates internationally. Photo: Bernd Wüstneck/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019052403500
2019年05月23日Chancellor visits biotech company Centogene23 May 2019, Mecklenburg-Western Pomerania, Rostock: During her visit to the biotech company Centogene, German Chancellor Angela Merkel (CDU, l) is informed about the facility by Arndt Rolfs, CEO, in the laboratory for DNA sequencing, right Manuela Schwesig (SPD), Minister President of Mecklenburg-Western Pomerania. Centogene AG specializes in the diagnosis and characterization of rare congenital diseases and operates internationally. Photo: Bernd Wüstneck/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019052403166
2019年05月23日Chancellor visits biotech company Centogene23 May 2019, Mecklenburg-Western Pomerania, Rostock: During their visit to the biotech company Centogene, German Chancellor Angela Merkel (CDU, 2nd from left) and Manuela Schwesig (SPD, 3rd from left), Minister President of Mecklenburg-Vorpommern, are informed about the facility by Kim Rössig (left) in the laboratory for DNA sequencing at the workplace. Centogene AG specializes in the diagnosis and characterization of rare congenital diseases and operates internationally. Photo: Bernd Wüstneck/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019052403437
2019年05月23日Chancellor visits biotech company Centogene23 May 2019, Mecklenburg-Western Pomerania, Rostock: During their visit to the biotech company Centogene, German Chancellor Angela Merkel (CDU, l) and Manuela Schwesig (SPD), Minister President of Mecklenburg-Western Pomerania, will be informed about the facility by Arndt Rolfs, CEO, in the DNA sequencing laboratory. Centogene AG specializes in the diagnosis and characterization of rare congenital diseases and operates internationally. Photo: Bernd Wüstneck/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019052403277
2019年05月23日Chancellor visits biotech company Centogene23 May 2019, Mecklenburg-Western Pomerania, Rostock: During their visit to the biotech company Centogene, German Chancellor Angela Merkel (CDU) and Manuela Schwesig (SPD, concealed), Minister President of Mecklenburg-Western Pomerania, are informed about the company by Arndt Rolfs, CEO, in the DNA sequencing laboratory. Centogene AG specializes in the diagnosis and characterization of rare congenital diseases and operates internationally. Photo: Bernd Wüstneck/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019052403325
2019年05月23日Chancellor visits biotech company Centogene23 May 2019, Mecklenburg-Western Pomerania, Rostock: During their visit to the biotech company Centogene, German Chancellor Angela Merkel (CDU, 2nd from left) and Manuela Schwesig (SPD, 3rd from left), Prime Minister of Mecklenburg-Vorpommern, are informed about the facility by Kim Rössig (left) at the workplace of Arndt Rolfs, CEO, in the laboratory for DNA sequencing. Centogene AG specializes in the diagnosis and characterization of rare congenital diseases and operates internationally. Photo: Bernd Wüstneck/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019052403272
2019年05月23日Chancellor visits biotech company Centogene23 May 2019, Mecklenburg-Western Pomerania, Rostock: During their visit to the biotech company Centogene, German Chancellor Angela Merkel (CDU, 2nd from left) and Manuela Schwesig (SPD, 3rd from left), Minister President of Mecklenburg-Vorpommern, are informed about the facility by Kim Rössig (left) in the laboratory for DNA sequencing at the workplace. Centogene AG specializes in the diagnosis and characterization of rare congenital diseases and operates internationally. Photo: Bernd Wüstneck/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2019052403489
2020年08月12日CHINA QINGDAO MARINE GENEBANKA researcher works in the National Marine Genebank operated by BGI in Qingdao in east China‘s Shandong province Wednesday, Aug. 12, 2020. The institute is currently working on a joint project to sequencing the genomics of 10,000 kinds of fish.、クレジット：Ｆｅａｔｕｒｅｃｈｉｎａ／共同通信イメージズ ※中国での使用禁止。
商品コード: 2020082101109
2020年08月12日CHINA QINGDAO MARINE GENEBANKResearchers work in the National Marine Genebank operated by BGI in Qingdao in east China‘s Shandong province Wednesday, Aug. 12, 2020. The institute is currently working on a joint project to sequencing the genomics of 10,000 kinds of fish.、クレジット：Ｆｅａｔｕｒｅｃｈｉｎａ／共同通信イメージズ ※中国での使用禁止。
商品コード: 2020082101043
2020年08月12日CHINA QINGDAO MARINE GENEBANKA researcher works in the National Marine Genebank operated by BGI in Qingdao in east China‘s Shandong province Wednesday, Aug. 12, 2020. The institute is currently working on a joint project to sequencing the genomics of 10,000 kinds of fish.、クレジット：Ｆｅａｔｕｒｅｃｈｉｎａ／共同通信イメージズ ※中国での使用禁止。
商品コード: 2020082101108
2020年08月12日CHINA QINGDAO MARINE GENEBANKA researcher works in the National Marine Genebank operated by BGI in Qingdao in east China‘s Shandong province Wednesday, Aug. 12, 2020. The institute is currently working on a joint project to sequencing the genomics of 10,000 kinds of fish.、クレジット：Ｆｅａｔｕｒｅｃｈｉｎａ／共同通信イメージズ ※中国での使用禁止。
商品コード: 2020082101125
2020年08月12日CHINA QINGDAO MARINE GENEBANKA researcher works in the National Marine Genebank operated by BGI in Qingdao in east China‘s Shandong province Wednesday, Aug. 12, 2020. The institute is currently working on a joint project to sequencing the genomics of 10,000 kinds of fish.、クレジット：Ｆｅａｔｕｒｅｃｈｉｎａ／共同通信イメージズ ※中国での使用禁止。
商品コード: 2020082101118
2020年08月12日Qingdao BGI Research InstituteA researcher at the BGI Research Institute in Qingdao loaded the sequencing chip. Qingdao, Shandong Province, China, Aug. 12.＝２０２０（令和２）年８月１２日、クレジット：ＣＦＯＴＯ／共同通信イメージズ
商品コード: 2021113015549
2020年08月12日Qingdao BGI Research InstituteA researcher at the BGI Research Institute in Qingdao loaded the sequencing chip. Qingdao, Shandong Province, China, Aug. 12.＝２０２０（令和２）年８月１２日、クレジット：ＣＦＯＴＯ／共同通信イメージズ
商品コード: 2021113015635
2020年08月12日Qingdao BGI Research InstituteA researcher at the BGI Research Institute in Qingdao reviewed the sequencing data. Qingdao, Shandong Province, China, Aug. 12.＝２０２０（令和２）年８月１２日、クレジット：ＣＦＯＴＯ／共同通信イメージズ
商品コード: 2021113015138
2020年10月20日Hong Kong News - October 20, 2020October 20, 2020, Hong Kong, CHINA: Professor Dennis Lo Yuk-ming with single use DNA cells for genome sequencing. Picture at Prince of Wales Hospital in Shatin. 20OCT20 SCMP / K. Y. Cheng (Credit Image: © K. Y. Cheng/South China Morning Post via ZUMA Wire)、クレジット：©Ｋ． Ｙ． Ｃｈｅｎｇ／Ｓｏｕｔｈ Ｃｈｉｎａ Ｍｏｒｎｉｎｇ Ｐｏｓｔ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2020102900035
2021年01月22日International Space Station Astronaut Kate RubinsJan 22, 2021 - Earth Atmosphere - NASA astronaut and Expedition 64 Flight Engineer Kate Rubins during DNA sequencing activities for an experiment that seeks to diagnose medical conditions and identify microbes aboard the International Space Station January 22, 2021 in Earth Orbit. (Credit Image: © NASA via ZUMA Wire)、クレジット：©ＮＡＳＡ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021041904194
2021年02月01日Coronavirus - Search for British Corona Mutant01 February 2021, Rhineland-Palatinate, Ingelheim: Oliver Harzer, Managing Director of Bioscientia Institut für Medizinische Diagnostik GmbH, stands at a machine for sequencing PCR tests. The British coroanvirus mutant B.1.1.7 is increasingly spreading. The company Bioscientia, one of the largest laboratories in Germany, is using automated sequencing machines to help with the analysis. (to dpa “Time-intensive and highly complex: The search for mutant B.1.1.7“) Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021020308328
2021年02月01日Coronavirus - Search for British Corona Mutant01 February 2021, Rhineland-Palatinate, Ingelheim: Ursular Wollscheid, medical technical assistant (MTA), works in a Bioscientia laboratory on a machine for sequencing PCR tests. The British coronavirus mutant B.1.1.7 is increasingly spreading. The company Bioscientia, one of the largest laboratories in Germany, is using automated sequencing machines to help with the analysis. (to dpa “Time-intensive and highly complex: The search for the B.1.1.7 mutant“) Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021020308487
2021年02月01日Coronavirus - Search for the British Mutant01 February 2021, Rhineland-Palatinate, Ingelheim: Oliver Harzer, MD, Managing Director/CEO Bioscientia Institut für Medizinische Diagnostik GmbH, stands at a machine for sequencing PCR tests. The British coroanvirus mutant B.1.1.7 is increasingly spreading. The company Bioscientia, one of the largest laboratories in Germany, is using automated sequencing machines to help with the analysis. (to “Time-consuming and highly complex: The search for the B.1.1.7 mutant“) Photo: Andreas Arnold/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021020308226
2021年02月12日GENOME SEQUENCING COVID-19 GENOME SEQUENCING COVID-19An 8 channel pipette is used when samples are prepared to look for mutations in the coronavirus SARS-CoV-2 in positive Covid-19 samples sent to the Center for Molecular Diagnostics at Region Sk蚣e‘s lab in Lund, Sweden.Photo: Johan Nilsson / TT / code 50090 ＝２０２１（令和３）年２月１２日、クレジット：ＴＴ Ｎｅｗｓ Ａｇｅｎｃｙ／共同通信イメージズ
商品コード: 2021021703452
2021年02月12日GENOME SEQUENCING COVID-19 GENOME SEQUENCING COVID-19An 8 channel pipette is used when samples are prepared to look for mutations in the coronavirus SARS-CoV-2 in positive Covid-19 samples sent to the Center for Molecular Diagnostics at Region Sk蚣e‘s lab in Lund, Sweden.Photo: Johan Nilsson / TT / code 50090 ＝２０２１（令和３）年２月１２日、クレジット：ＴＴ Ｎｅｗｓ Ａｇｅｎｃｙ／共同通信イメージズ
商品コード: 2021021703447
2021年02月12日GENOME SEQUENCING COVID-19 GENOME SEQUENCING COVID-19An 8 channel pipette is used when samples are prepared to look for mutations in the coronavirus SARS-CoV-2 in positive Covid-19 samples sent to the Center for Molecular Diagnostics at Region Sk蚣e‘s lab in Lund, Sweden.Photo: Johan Nilsson / TT / code 50090 ＝２０２１（令和３）年２月１２日、クレジット：ＴＴ Ｎｅｗｓ Ａｇｅｎｃｙ／共同通信イメージズ
商品コード: 2021021703457
2021年02月12日GENOME SEQUENCING COVID-19 GENOME SEQUENCING COVID-19A flow cell is fed into the sequencing instrument used to search for mutations of the coronavirus SARS-CoV-2 in positive Covid-19 samples sent to Region Sk蚣e‘s lab in Lund, Sweden. Photo: Johan Nilsson / TT / code 50090 ＝２０２１（令和３）年２月１２日、クレジット：ＴＴ Ｎｅｗｓ Ａｇｅｎｃｙ／共同通信イメージズ
商品コード: 2021021703459
2021年02月12日GENOME SEQUENCING COVID-19 GENOME SEQUENCING COVID-19A flow cell is fed into the sequencing instrument used to search for mutations of the coronavirus SARS-CoV-2 in positive Covid-19 samples sent to Region Sk蚣e‘s lab in Lund, Sweden. Photo: Johan Nilsson / TT / code 50090 ＝２０２１（令和３）年２月１２日、クレジット：ＴＴ Ｎｅｗｓ Ａｇｅｎｃｙ／共同通信イメージズ
商品コード: 2021021703442
2021年02月12日GENOME SEQUENCING COVID-19 GENOME SEQUENCING COVID-19A flow cell is fed into the sequencing instrument used to search for mutations of the coronavirus SARS-CoV-2 in positive Covid-19 samples sent to Region Sk蚣e‘s lab in Lund, Sweden. Photo: Johan Nilsson / TT / code 50090 ＝２０２１（令和３）年２月１２日、クレジット：ＴＴ Ｎｅｗｓ Ａｇｅｎｃｙ／共同通信イメージズ
商品コード: 2021021703461
2021年02月12日GENOME SEQUENCING COVID-19 GENOME SEQUENCING COVID-19The sequencing instrument used to detect mutations in the coronavirus SARS-CoV-2 in positive Covid-19 samples sent to the Center for Molecular Diagnostics at Region Sk蚣e‘s lab in Lund, Sweden.Photo: Johan Nilsson / TT / code 50090 ＝２０２１（令和３）年２月１２日、クレジット：ＴＴ Ｎｅｗｓ Ａｇｅｎｃｙ／共同通信イメージズ
商品コード: 2021021703441
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: Theresia Bauer (Bündnis 90/Die Grünen), Baden-Württemberg‘s Minister of Science, speaks at a press conference at the European Molecular Biology Laboratory (EMBL). In an EMBL laboratory, positive SARS-CoV-2 samples are systematically examined for mutations. The aim is to quickly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030510101
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: Vladimir Benes, Head of Genomics Core Facility, takes a container out of a cabinet in a sequencing laboratory at the European Molecular Biology Laboratory (EMBL). In the lab, positive SARS-CoV-2 samples are systematically screened for alterations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030510340
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: An employee holds a so-called flowcell next to a model of a DNA helix in a sequencing laboratory at the European Molecular Biology Laboratory (EMBL). In the laboratory, positive SARS-CoV-2 samples are systematically examined for mutations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030510270
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: An employee holds a so-called flowcell in a sequencing laboratory at the European Molecular Biology Laboratory (EMBL). In the laboratory, positive SARS-CoV-2 samples are systematically examined for mutations. The aim is to quickly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030510032
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: An employee holds a so-called flowcell above a DNA sequencer in a sequencing laboratory at the European Molecular Biology Laboratory (EMBL). In the laboratory, positive SARS-CoV-2 samples are systematically examined for mutations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030510187
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: Vladimir Benes, Head of the Genomics Department, holds a so-called flowcell above a DNA sequencer in a sequencing laboratory at the European Molecular Biology Laboratory (EMBL). In the lab, positive SARS-CoV-2 samples are systematically screened for alterations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030510305
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: An employee in a sequencing laboratory at the European Molecular Biology Laboratory (EMBL) holds a so-called flowcell in his hands next to a DNA sequencer. In the laboratory, positive SARS-CoV-2 samples are systematically examined for mutations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030509850
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: An employee takes a container from a cabinet in a sequencing laboratory at the European Molecular Biology Laboratory (EMBL). In the laboratory, positive SARS-CoV-2 samples are systematically screened for alterations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030510071
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: Peer Bork (l-r), Director of EMBL-Heidelberg, Theresia Bauer (Bündnis 90/Die Grünen), Baden-Württemberg‘s Minister of Science, and Hans-Georg Kräusslich, Dean of the Medical Faculty and Member of the Board of Heidelberg University Hospital, arrive at a press conference at the European Molecular Biology Laboratory (EMBL). In an EMBL laboratory, positive SARS-CoV-2 samples are systematically examined for mutations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030509989
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: Theresia Bauer (Bündnis 90/Die Grünen, M), Baden-Württemberg‘s Minister of Science, sits on the podium between Peer Bork (r), Director of EMBL-Heidelberg, and Hans-Georg Kräusslich, Dean of the Faculty of Medicine and Member of the Board of Heidelberg University Hospital, at a press conference at the European Molecular Biology Laboratory (EMBL). In an EMBL laboratory, positive SARS-CoV-2 samples are systematically examined for mutations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030510403
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: An employee takes a container from a cabinet in a sequencing laboratory at the European Molecular Biology Laboratory (EMBL). In the laboratory, positive SARS-CoV-2 samples are systematically screened for alterations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030509900
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: An employee holds a so-called flowcell in a sequencing laboratory at the European Molecular Biology Laboratory (EMBL). In the laboratory, positive SARS-CoV-2 samples are systematically examined for mutations. The aim is to quickly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030509990
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: Hans-Georg Kräusslich, Dean of the Faculty of Medicine and Member of the Board of Heidelberg University Hospital, stands in the European Molecular Biology Laboratory (EMBL). In an EMBL laboratory, positive SARS-CoV-2 samples are systematically examined for mutations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030510159
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: Theresia Bauer (Bündnis 90/Die Grünen), Baden-Württemberg‘s Minister of Science, addresses a press conference during an interview at the European Molecular Biology Laboratory (EMBL). In an EMBL laboratory, positive SARS-CoV-2 samples are systematically examined for mutations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030510326
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: An employee holds a so-called flowcell in a sequencing laboratory at the European Molecular Biology Laboratory (EMBL). In the laboratory, positive SARS-CoV-2 samples are systematically examined for mutations. The aim is to quickly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030509827
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: Vladimir Benes, Head of Genomics Core Facility, takes a container out of a cabinet in a sequencing laboratory at the European Molecular Biology Laboratory (EMBL). In the lab, positive SARS-CoV-2 samples are systematically screened for alterations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030509885
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: An employee holds a so-called flowcell next to a model of a DNA helix in a sequencing laboratory at the European Molecular Biology Laboratory (EMBL). In the laboratory, positive SARS-CoV-2 samples are systematically examined for mutations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030510245
2021年03月04日Coronavirus - sequencing of SARS-CoV-2 samples04 March 2021, Baden-Wuerttemberg, Heidelberg: Hans-Georg Kräusslich, Dean of the Faculty of Medicine and Member of the Board of Heidelberg University Hospital, stands in the European Molecular Biology Laboratory (EMBL). In an EMBL laboratory, positive SARS-CoV-2 samples are systematically examined for mutations. The aim is to rapidly identify mutations that pose a particular risk in terms of transmissibility, disease severity and vaccine efficacy. Photo: Uwe Anspach/dpa、クレジット：ＤＰＡ／共同通信イメージズ
商品コード: 2021030510166
2021年03月08日Sars CoV-2 Virus Analysis And Identification ProcessMarch 8, 2021, Varese, Italy: Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi with researcher during the research analysis (Credit Image: © Nick Zonna/IPA via ZUMA Press)、クレジット：©Ｎｉｃｋ Ｚｏｎｎａ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021030908719
2021年03月08日Sars CoV-2 Virus Analysis And Identification ProcessMarch 8, 2021, Varese, Italy: Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi with researcher during the research analysis (Credit Image: © Nick Zonna/IPA via ZUMA Press)、クレジット：©Ｎｉｃｋ Ｚｏｎｎａ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021030908816
2021年03月08日Sars CoV-2 Virus Analysis And Identification ProcessMarch 8, 2021, Varese, Italy: Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi with researcher during the research analysis (Credit Image: © Nick Zonna/IPA via ZUMA Press)、クレジット：©Ｎｉｃｋ Ｚｏｎｎａ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021030909302
2021年03月08日Sars CoV-2 Virus Analysis And Identification ProcessMarch 8, 2021, Varese, Italy: Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi (Credit Image: © Nick Zonna/IPA via ZUMA Press)、クレジット：©Ｎｉｃｋ Ｚｏｎｎａ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021030908812
2021年03月08日Sars CoV-2 Virus Analysis And Identification ProcessMarch 8, 2021, Varese, Italy: Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi (Credit Image: © Nick Zonna/IPA via ZUMA Press)、クレジット：©Ｎｉｃｋ Ｚｏｎｎａ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021030908948
2021年03月08日Sars CoV-2 Virus Analysis And Identification ProcessMarch 8, 2021, Varese, Italy: Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi (Credit Image: © Nick Zonna/IPA via ZUMA Press)、クレジット：©Ｎｉｃｋ Ｚｏｎｎａ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021030908715
2021年03月08日Sars CoV-2 Virus Analysis And Identification ProcessMarch 8, 2021, Varese, Italy: Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi (Credit Image: © Nick Zonna/IPA via ZUMA Press)、クレジット：©Ｎｉｃｋ Ｚｏｎｎａ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021030909063
2021年03月08日Sars CoV-2 Virus Analysis And Identification ProcessMarch 8, 2021, Varese, Italy: Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi (Credit Image: © Nick Zonna/IPA via ZUMA Press)、クレジット：©Ｎｉｃｋ Ｚｏｎｎａ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021030908913
2021年03月08日Sars CoV-2 Virus Analysis And Identification ProcessMarch 8, 2021, Varese, Italy: Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi (Credit Image: © Nick Zonna/IPA via ZUMA Press)、クレジット：©Ｎｉｃｋ Ｚｏｎｎａ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021030909035
2021年03月08日Sars CoV-2 Virus Analysis And Identification ProcessMarch 8, 2021, Varese, Italy: Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi (Credit Image: © Nick Zonna/IPA via ZUMA Press)、クレジット：©Ｎｉｃｋ Ｚｏｎｎａ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021030909375
2021年03月08日Sars CoV-2 Virus Analysis And Identification ProcessMarch 8, 2021, Varese, Italy: Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi (Credit Image: © Nick Zonna/IPA via ZUMA Press)、クレジット：©Ｎｉｃｋ Ｚｏｎｎａ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021030908954
2021年03月08日Sars CoV-2 Virus Analysis And Identification ProcessMarch 8, 2021, Varese, Italy: Varese, Italy ASST Sette Laghi Research procedure in the microbiology laboratory led by Prof. Fabrizio Maggi and his team during the reconstruction of the new virus genome with the sequencing of the entire instrumental of the entire spike protein, the part of the Sars CoV- 2 In the photo: Prof. Fabrizio Maggi (Credit Image: © Nick Zonna/IPA via ZUMA Press)、クレジット：©Ｎｉｃｋ Ｚｏｎｎａ／ＩＰＡ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｅｕｒｏｐｅ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021030908458
2021年04月15日Badajoz Hospital is looking for Covid-19 variantsApril 15, 2021, Badajoz (Extremadura, Madrid, Spain: A researcher works in the Microbiology laboratory of the University Hospital of Badajoz, on April 15, 2021. In this laboratory they carry out the sequencing of coronavirus samples to confirm some of the most dangerous mutations that have occurred so far. Their aim is to detect whether the British, Brazilian or South African strains are present in Extremadura...15 APRIL 2021;COVID;TRIALS;CORONAVIRUS;VARIANTS;STRAINS;VIRUS;PANDEMIC;LABORATORY;RESEARCH..JAVIER PULPO / Europa Press..04/15/2021 (Credit Image: © Javier Pulpo/Contacto via ZUMA Press)、クレジット：©Ｊａｖｉｅｒ Ｐｕｌｐｏ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021042007963
2021年04月15日Badajoz Hospital is looking for Covid-19 variantsApril 15, 2021, Badajoz (Extremadura, Madrid, Spain: A researcher works in the Microbiology laboratory of the University Hospital of Badajoz, on April 15, 2021. In this laboratory they carry out the sequencing of coronavirus samples to confirm some of the most dangerous mutations that have occurred so far. Their aim is to detect whether the British, Brazilian or South African strains are present in Extremadura...15 APRIL 2021;COVID;TRIALS;CORONAVIRUS;VARIANTS;STRAINS;VIRUS;PANDEMIC;LABORATORY;RESEARCH..JAVIER PULPO / Europa Press..04/15/2021 (Credit Image: © Javier Pulpo/Contacto via ZUMA Press)、クレジット：©Ｊａｖｉｅｒ Ｐｕｌｐｏ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021042007970
2021年04月15日Badajoz Hospital is looking for Covid-19 variantsApril 15, 2021, Badajoz (Extremadura, Madrid, Spain: Several researchers work in the Microbiology laboratory of the University Hospital of Badajoz, on 15 April 2021. In this laboratory they carry out the sequencing of coronavirus samples to confirm some of the most dangerous mutations that have occurred so far. Their aim is to detect whether the British, Brazilian or South African strains are present in Extremadura...15 APRIL 2021;COVID;TRIALS;CORONAVIRUS;VARIANTS;STRAINS;VIRUS;PANDEMIC;LABORATORY;RESEARCH..JAVIER PULPO / Europa Press..04/15/2021 (Credit Image: © Javier Pulpo/Contacto via ZUMA Press)、クレジット：©Ｊａｖｉｅｒ Ｐｕｌｐｏ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021042007656
2021年04月15日Badajoz Hospital is looking for Covid-19 variantsApril 15, 2021, Badajoz (Extremadura, Madrid, Spain: One of the rooms of the Microbiology laboratory of the University Hospital of Badajoz, on 15 April 2021. In this laboratory they perform the sequencing of coronavirus samples to confirm some of the most dangerous mutations that have occurred so far. Their aim is to detect whether the British, Brazilian or South African strains are present in Extremadura...15 APRIL 2021;COVID;TRIALS;CORONAVIRUS;VARIANTS;STRAINS;VIRUS;PANDEMIC;LABORATORY;RESEARCH..JAVIER PULPO / Europa Press..04/15/2021 (Credit Image: © Javier Pulpo/Contacto via ZUMA Press)、クレジット：©Ｊａｖｉｅｒ Ｐｕｌｐｏ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021042007668
2021年04月15日Badajoz Hospital is looking for Covid-19 variantsApril 15, 2021, Badajoz (Extremadura, Madrid, Spain: A researcher works in the Microbiology laboratory of the University Hospital of Badajoz, on April 15, 2021. In this laboratory they carry out the sequencing of coronavirus samples to confirm some of the most dangerous mutations that have occurred so far. Their aim is to detect whether the British, Brazilian or South African strains are present in Extremadura...15 APRIL 2021;COVID;TRIALS;CORONAVIRUS;VARIANTS;STRAINS;VIRUS;PANDEMIC;LABORATORY;RESEARCH..JAVIER PULPO / Europa Press..04/15/2021 (Credit Image: © Javier Pulpo/Contacto via ZUMA Press)、クレジット：©Ｊａｖｉｅｒ Ｐｕｌｐｏ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021042007664
2021年04月15日Badajoz Hospital is looking for Covid-19 variantsApril 15, 2021, Badajoz (Extremadura, Madrid, Spain: One of the devices used to work in the Microbiology laboratory of the University Hospital of Badajoz, on 15 April 2021. In this laboratory they perform the sequencing of coronavirus samples to confirm some of the most dangerous mutations that have occurred so far. Their aim is to detect whether the British, Brazilian or South African strains are present in Extremadura...15 APRIL 2021;COVID;TRIALS;CORONAVIRUS;VARIANTS;STRAINS;VIRUS;PANDEMIC;LABORATORY;RESEARCH..JAVIER PULPO / Europa Press..04/15/2021 (Credit Image: © Javier Pulpo/Contacto via ZUMA Press)、クレジット：©Ｊａｖｉｅｒ Ｐｕｌｐｏ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021042008451
2021年04月15日Badajoz Hospital is looking for Covid-19 variantsApril 15, 2021, Badajoz (Extremadura, Madrid, Spain: A researcher works in the Microbiology laboratory of the University Hospital of Badajoz, on April 15, 2021. In this laboratory they carry out the sequencing of coronavirus samples to confirm some of the most dangerous mutations that have occurred so far. Their aim is to detect whether the British, Brazilian or South African strains are present in Extremadura...15 APRIL 2021;COVID;TRIALS;CORONAVIRUS;VARIANTS;STRAINS;VIRUS;PANDEMIC;LABORATORY;RESEARCH..JAVIER PULPO / Europa Press..04/15/2021 (Credit Image: © Javier Pulpo/Contacto via ZUMA Press)、クレジット：©Ｊａｖｉｅｒ Ｐｕｌｐｏ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021042007729
2021年04月15日Badajoz Hospital is looking for Covid-19 variantsApril 15, 2021, Badajoz (Extremadura, Madrid, Spain: Biological substance canisters in the Microbiology laboratory of the University Hospital of Badajoz, on 15 April 2021. In this laboratory they perform the sequencing of coronavirus samples to confirm some of the most dangerous mutations that have occurred so far. Their aim is to detect whether the British, Brazilian or South African strains are present in Extremadura...15 APRIL 2021;COVID;TRIALS;CORONAVIRUS;VARIANTS;STRAINS;VIRUS;PANDEMIC;LABORATORY;RESEARCH..JAVIER PULPO / Europa Press..04/15/2021 (Credit Image: © Javier Pulpo/Contacto via ZUMA Press)、クレジット：©Ｊａｖｉｅｒ Ｐｕｌｐｏ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021042007732
2021年04月15日Badajoz Hospital is looking for Covid-19 variantsApril 15, 2021, Badajoz (Extremadura, Madrid, Spain: A researcher works in the Microbiology laboratory of the University Hospital of Badajoz, on April 15, 2021. In this laboratory they carry out the sequencing of coronavirus samples to confirm some of the most dangerous mutations that have occurred so far. Their aim is to detect whether the British, Brazilian or South African strains are present in Extremadura...15 APRIL 2021;COVID;TRIALS;CORONAVIRUS;VARIANTS;STRAINS;VIRUS;PANDEMIC;LABORATORY;RESEARCH..JAVIER PULPO / Europa Press..04/15/2021 (Credit Image: © Javier Pulpo/Contacto via ZUMA Press)、クレジット：©Ｊａｖｉｅｒ Ｐｕｌｐｏ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021042007830
2021年04月15日Badajoz Hospital is looking for Covid-19 variantsApril 15, 2021, Badajoz (Extremadura, Madrid, Spain: A researcher works with the computer in the Microbiology laboratory of the University Hospital of Badajoz, on 15 April 2021. In this laboratory they carry out the sequencing of coronavirus samples to confirm some of the most dangerous mutations that have occurred so far. Their aim is to detect whether the British, Brazilian or South African strains are present in Extremadura...15 APRIL 2021;COVID;TRIALS;CORONAVIRUS;VARIANTS;STRAINS;VIRUS;PANDEMIC;LABORATORY;RESEARCH..JAVIER PULPO / Europa Press..04/15/2021 (Credit Image: © Javier Pulpo/Contacto via ZUMA Press)、クレジット：©Ｊａｖｉｅｒ Ｐｕｌｐｏ／Ｃｏｎｔａｃｔｏ ｖｉａ ＺＵＭＡ Ｐｒｅｓｓ／共同通信イメージズ ※Ｆｒａｎｃｅ， Ｇｅｒｍａｎｙ ， ＵＫ ａｎｄ Ｓｐａｉｎ Ｒｉｇｈｔｓ ＯＵＴ
商品コード: 2021042007653
2021年05月25日COVID Pandemic Year 2May 25, 2021, New York, New York, USA: Sarasota, Florida. The Centers for Disease Control and Prevention has stopped investigating infections among fully vaccinated people unless they become so sick that they are hospitalized or die. Through the end of April, when 101 million Americans had been vaccinated, the C.D.C. had received 10,262 reports of infections from 46 states. Genomic sequencing could be done on only 555 of the reported breakthrough cases. Half of them involved variants of concern, including the B.1.1.7 and B.1.351. 995 people were known to have been hospitalized, and 160 had died. The median age of those who died was 82. The agency will carry out vaccine effectiveness studies that include data on breakthrough cases in populations such as health care workers and essential workers, older adults, and residents at long-term care facilities. (Credit Image: © John Marshall Mantel/ZUMA Wire)、クレジット：©Ｊｏｈｎ Ｍａｒｓｈａｌｌ Ｍａｎｔｅｌ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021052606284
2021年05月25日COVID Pandemic Year 2May 25, 2021, New York, New York, USA: Sarasota, Florida. The Centers for Disease Control and Prevention has stopped investigating infections among fully vaccinated people unless they become so sick that they are hospitalized or die. Through the end of April, when 101 million Americans had been vaccinated, the C.D.C. had received 10,262 reports of infections from 46 states. Genomic sequencing could be done on only 555 of the reported breakthrough cases. Half of them involved variants of concern, including the B.1.1.7 and B.1.351. 995 people were known to have been hospitalized, and 160 had died. The median age of those who died was 82. The agency will carry out vaccine effectiveness studies that include data on breakthrough cases in populations such as health care workers and essential workers, older adults, and residents at long-term care facilities. (Credit Image: © John Marshall Mantel/ZUMA Wire)、クレジット：©Ｊｏｈｎ Ｍａｒｓｈａｌｌ Ｍａｎｔｅｌ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021052606316
2021年06月05日Wild Animals: Florida Life and EconomyJune 4, 2021, SARASOTA, FLORIDA, USA: Sarasota, Florida. The Centers for Disease Control and Prevention has stopped investigating infections among fully vaccinated people unless they become so sick that they are hospitalized or die. Through the end of April, when 101 million Americans had been vaccinated, the C.D.C. had received 10,262 reports of infections from 46 states. Genomic sequencing could be done on only 555 of the reported breakthrough cases. Half of them involved variants of concern, including the B.1.1.7 and B.1.351. 995 people were known to have been hospitalized, and 160 had died. The median age of those who died was 82. The agency will carry out vaccine effectiveness studies that include data on breakthrough cases in populations such as essential workers. (Credit Image: © John Marshall Mantel/ZUMA Wire)、クレジット：©Ｊｏｈｎ Ｍａｒｓｈａｌｌ Ｍａｎｔｅｌ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021060603552
2021年06月07日COVID Pandemic Year 2June 6, 2021, Sarasota, Florida, USA: Sarasota, Florida. The Centers for Disease Control and Prevention has stopped investigating infections among fully vaccinated people unless they become so sick that they are hospitalized or die. Through the end of April, when 101 million Americans had been vaccinated, the C.D.C. had received 10,262 reports of infections from 46 states. Genomic sequencing could be done on only 555 of the reported breakthrough cases. (Credit Image: © John Marshall Mantel/ZUMA Wire)、クレジット：©Ｊｏｈｎ Ｍａｒｓｈａｌｌ Ｍａｎｔｅｌ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021060804185
2021年06月07日COVID Pandemic Year 2June 6, 2021, Sarasota, Florida, USA: Sarasota, Florida. The Centers for Disease Control and Prevention has stopped investigating infections among fully vaccinated people unless they become so sick that they are hospitalized or die. Through the end of April, when 101 million Americans had been vaccinated, the C.D.C. had received 10,262 reports of infections from 46 states. Genomic sequencing could be done on only 555 of the reported breakthrough cases. (Credit Image: © John Marshall Mantel/ZUMA Wire)、クレジット：©Ｊｏｈｎ Ｍａｒｓｈａｌｌ Ｍａｎｔｅｌ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021060804229
2021年06月07日COVID Pandemic Year 2June 6, 2021, Sarasota, Florida, USA: Sarasota, Florida. The Centers for Disease Control and Prevention has stopped investigating infections among fully vaccinated people unless they become so sick that they are hospitalized or die. Through the end of April, when 101 million Americans had been vaccinated, the C.D.C. had received 10,262 reports of infections from 46 states. Genomic sequencing could be done on only 555 of the reported breakthrough cases. (Credit Image: © John Marshall Mantel/ZUMA Wire)、クレジット：©Ｊｏｈｎ Ｍａｒｓｈａｌｌ Ｍａｎｔｅｌ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021060804224
2021年06月07日COVID Pandemic Year 2June 6, 2021, Sarasota, Florida, USA: Sarasota, Florida. The Centers for Disease Control and Prevention has stopped investigating infections among fully vaccinated people unless they become so sick that they are hospitalized or die. Through the end of April, when 101 million Americans had been vaccinated, the C.D.C. had received 10,262 reports of infections from 46 states. Genomic sequencing could be done on only 555 of the reported breakthrough cases. (Credit Image: © John Marshall Mantel/ZUMA Wire)、クレジット：©Ｊｏｈｎ Ｍａｒｓｈａｌｌ Ｍａｎｔｅｌ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021060804249
2021年06月07日Wild Animals: Florida Life and EconomyJune 6, 2021, SARASOTA, FLORIDA, USA: Sarasota, Florida. The Centers for Disease Control and Prevention has stopped investigating infections among fully vaccinated people unless they become so sick that they are hospitalized or die. Through the end of April, when 101 million Americans had been vaccinated, the C.D.C. had received 10,262 reports of infections from 46 states. Genomic sequencing could be done on only 555 of the reported breakthrough cases. (Credit Image: © John Marshall Mantel/ZUMA Wire)、クレジット：©Ｊｏｈｎ Ｍａｒｓｈａｌｌ Ｍａｎｔｅｌ／ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021060804219
2021年06月27日India: COVID-19 Vaccination after Delta-plus variant found in RajasthanJune 27, 2021, Beawar, Rajasthan, India: Beneficiaries stand in queues to receive COVID-19 Vaccine during a special vaccination drive at a vaccination center in Beawar. The first case of the Delta-plus variant of coronavirus in Rajasthan was found in Bikaner. The sample of a woman who was tested positive for coronavirus was sent to the National Institute of Virology in Pune on May 30 for genome sequencing and her test report came on June 25. Total 48 cases of Delta plus and four deaths reported in 10 states in India. (Credit Image: © Sumit Saraswat/Pacific Press via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｒａｓｗａｔ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021062805167
2021年06月27日India: COVID-19 Vaccination after Delta-plus variant found in RajasthanJune 27, 2021, Beawar, Rajasthan, India: A health worker administers a dose of Covishield (COVID-19 Vaccine) to a rural woman during a special vaccination drive at a vaccination center in Beawar. The first case of the Delta-plus variant of coronavirus in Rajasthan was found in Bikaner. The sample of a woman who was tested positive for coronavirus was sent to the National Institute of Virology in Pune on May 30 for genome sequencing and her test report came on June 25. Total 48 cases of Delta plus and four deaths reported in 10 states in India. (Credit Image: © Sumit Saraswat/Pacific Press via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｒａｓｗａｔ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021062805088
2021年06月27日India: COVID-19 Vaccination after Delta-plus variant found in RajasthanJune 27, 2021, Beawar, Rajasthan, India: A health worker administers a dose of Covishield (COVID-19 Vaccine) to a woman during a special vaccination drive at a vaccination center in Beawar. The first case of the Delta-plus variant of coronavirus in Rajasthan was found in Bikaner. The sample of a woman who was tested positive for coronavirus was sent to the National Institute of Virology in Pune on May 30 for genome sequencing and her test report came on June 25. Total 48 cases of Delta plus and four deaths reported in 10 states in India. (Credit Image: © Sumit Saraswat/Pacific Press via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｒａｓｗａｔ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021062805057
2021年06月27日India: COVID-19 Vaccination after Delta-plus variant found in RajasthanJune 27, 2021, Beawar, Rajasthan, India: A young beneficiary reacts as she receives a dose of Covishield (COVID-19 Vaccine) during a special vaccination drive at a vaccination center in Beawar. The first case of the Delta-plus variant of coronavirus in Rajasthan was found in Bikaner. The sample of a woman who was tested positive for coronavirus was sent to the National Institute of Virology in Pune on May 30 for genome sequencing and her test report came on June 25. Total 48 cases of Delta plus and four deaths reported in 10 states in India. (Credit Image: © Sumit Saraswat/Pacific Press via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｒａｓｗａｔ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021062805175
2021年06月27日India: COVID-19 Vaccination after Delta-plus variant found in RajasthanJune 27, 2021, Beawar, Rajasthan, India: A vial of Covishield (COVID-19 Vaccine) during a special vaccination drive at a vaccination center in Beawar. The first case of the Delta-plus variant of coronavirus in Rajasthan was found in Bikaner. The sample of a woman who was tested positive for coronavirus was sent to the National Institute of Virology in Pune on May 30 for genome sequencing and her test report came on June 25. Total 48 cases of Delta plus and four deaths reported in 10 states in India. (Credit Image: © Sumit Saraswat/Pacific Press via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｒａｓｗａｔ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021062805120
2021年06月27日India: COVID-19 Vaccination after Delta-plus variant found in RajasthanJune 27, 2021, Beawar, Rajasthan, India: A young beneficiary reacts as she receives a dose of Covishield (COVID-19 Vaccine) during a special vaccination drive at a vaccination center in Beawar. The first case of the Delta-plus variant of coronavirus in Rajasthan was found in Bikaner. The sample of a woman who was tested positive for coronavirus was sent to the National Institute of Virology in Pune on May 30 for genome sequencing and her test report came on June 25. Total 48 cases of Delta plus and four deaths reported in 10 states in India. (Credit Image: © Sumit Saraswat/Pacific Press via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｒａｓｗａｔ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021062804967
2021年06月27日India: COVID-19 Vaccination after Delta-plus variant found in RajasthanJune 27, 2021, Beawar, Rajasthan, India: Health workers take residents details for COVID-19 Vaccine during a special vaccination drive at a vaccination center in Beawar. The first case of the Delta-plus variant of coronavirus in Rajasthan was found in Bikaner. The sample of a woman who was tested positive for coronavirus was sent to the National Institute of Virology in Pune on May 30 for genome sequencing and her test report came on June 25. Total 48 cases of Delta plus and four deaths reported in 10 states in India. (Credit Image: © Sumit Saraswat/Pacific Press via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｒａｓｗａｔ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021062804955
2021年06月27日India: COVID-19 Vaccination after Delta-plus variant found in RajasthanJune 27, 2021, Beawar, Rajasthan, India: A beneficiary reacts as she receives a dose of Covishield (COVID-19 Vaccine) during a special vaccination drive at a vaccination center in Beawar. The first case of the Delta-plus variant of coronavirus in Rajasthan was found in Bikaner. The sample of a woman who was tested positive for coronavirus was sent to the National Institute of Virology in Pune on May 30 for genome sequencing and her test report came on June 25. Total 48 cases of Delta plus and four deaths reported in 10 states in India. (Credit Image: © Sumit Saraswat/Pacific Press via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｒａｓｗａｔ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021062804952
2021年06月27日India: COVID-19 Vaccination after Delta-plus variant found in RajasthanJune 27, 2021, Beawar, Rajasthan, India: Health workers administer a dose of Covishield (COVID-19 Vaccine) to beneficiaries during a special vaccination drive at a vaccination center in Beawar. The first case of the Delta-plus variant of coronavirus in Rajasthan was found in Bikaner. The sample of a woman who was tested positive for coronavirus was sent to the National Institute of Virology in Pune on May 30 for genome sequencing and her test report came on June 25. Total 48 cases of Delta plus and four deaths reported in 10 states in India. (Credit Image: © Sumit Saraswat/Pacific Press via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｒａｓｗａｔ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021062805132
2021年06月27日India: COVID-19 Vaccination after Delta-plus variant found in RajasthanJune 27, 2021, Beawar, Rajasthan, India: A muslim man reacts as he receives a dose of Covishield (COVID-19 Vaccine) during a special vaccination drive at a vaccination center in Beawar. The first case of the Delta-plus variant of coronavirus in Rajasthan was found in Bikaner. The sample of a woman who was tested positive for coronavirus was sent to the National Institute of Virology in Pune on May 30 for genome sequencing and her test report came on June 25. Total 48 cases of Delta plus and four deaths reported in 10 states in India. (Credit Image: © Sumit Saraswat/Pacific Press via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｒａｓｗａｔ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021062805097
2021年06月27日India: COVID-19 Vaccination after Delta-plus variant found in RajasthanJune 27, 2021, Beawar, Rajasthan, India: A health worker administers a dose of Covishield (COVID-19 Vaccine) to a beneficiary during a special vaccination drive at a vaccination center in Beawar. The first case of the Delta-plus variant of coronavirus in Rajasthan was found in Bikaner. The sample of a woman who was tested positive for coronavirus was sent to the National Institute of Virology in Pune on May 30 for genome sequencing and her test report came on June 25. Total 48 cases of Delta plus and four deaths reported in 10 states in India. (Credit Image: © Sumit Saraswat/Pacific Press via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｒａｓｗａｔ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021062804951
2021年06月27日India: COVID-19 Vaccination after Delta-plus variant found in RajasthanJune 27, 2021, Beawar, Rajasthan, India: Health workers take residents details for COVID-19 Vaccine during a special vaccination drive at a vaccination center in Beawar. The first case of the Delta-plus variant of coronavirus in Rajasthan was found in Bikaner. The sample of a woman who was tested positive for coronavirus was sent to the National Institute of Virology in Pune on May 30 for genome sequencing and her test report came on June 25. Total 48 cases of Delta plus and four deaths reported in 10 states in India. (Credit Image: © Sumit Saraswat/Pacific Press via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｒａｓｗａｔ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021062805156
2021年06月27日India: COVID-19 Vaccination after Delta-plus variant found in RajasthanJune 27, 2021, Beawar, Rajasthan, India: Beneficiaries stand in queues to receive COVID-19 Vaccine during a special vaccination drive at a vaccination center in Beawar. The first case of the Delta-plus variant of coronavirus in Rajasthan was found in Bikaner. The sample of a woman who was tested positive for coronavirus was sent to the National Institute of Virology in Pune on May 30 for genome sequencing and her test report came on June 25. Total 48 cases of Delta plus and four deaths reported in 10 states in India. (Credit Image: © Sumit Saraswat/Pacific Press via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｒａｓｗａｔ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021062805099
2021年06月27日India: COVID-19 Vaccination after Delta-plus variant found in RajasthanJune 27, 2021, Beawar, Rajasthan, India: A young beneficiary reacts as she receives a dose of Covishield (COVID-19 Vaccine) during a special vaccination drive at a vaccination center in Beawar. The first case of the Delta-plus variant of coronavirus in Rajasthan was found in Bikaner. The sample of a woman who was tested positive for coronavirus was sent to the National Institute of Virology in Pune on May 30 for genome sequencing and her test report came on June 25. Total 48 cases of Delta plus and four deaths reported in 10 states in India. (Credit Image: © Sumit Saraswat/Pacific Press via ZUMA Wire)、クレジット：©Ｓｕｍｉｔ Ｓａｒａｓｗａｔ／Ｐａｃｉｆｉｃ Ｐｒｅｓｓ ｖｉａ ＺＵＭＡ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021062805109
2021年07月30日Return to NormalcyJuly 30, 2021, PORTLAND, OREGON, USA: The spread of the Delta variant is claiming lives and threatening a return to normalcy in the United States. 605,780 Americans have died from the virus, more than the total number of Americans killed in World War I and World War II combined. The surging delta variant of COVID-19 makes up at least 88% of all cases in Oregon, according to Oregon Health and Sciences University Genome Sequencing Center. Health officials linked the increase to the more contagious delta variant, and reiterated unvaccinated people are most at risk. (Credit Image: © John Marshall Mantel/ZUMA Press Wire)、クレジット：©Ｊｏｈｎ Ｍａｒｓｈａｌｌ Ｍａｎｔｅｌ／ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021080302202
2021年07月31日Return to NormalcyJuly 31, 2021, PORTLAND, OREGON, USA: The spread of the Delta variant is claiming lives and threatening a return to normalcy in the United States. 605,780 Americans have died from the virus, more than the total number of Americans killed in World War I and World War II combined. The surging delta variant of COVID-19 makes up at least 88% of all cases in Oregon, according to Oregon Health and Sciences University Genome Sequencing Center. Health officials linked the increase to the more contagious delta variant, and reiterated unvaccinated people are most at risk. (Credit Image: © John Marshall Mantel/ZUMA Press Wire)、クレジット：©Ｊｏｈｎ Ｍａｒｓｈａｌｌ Ｍａｎｔｅｌ／ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021080302110
2021年07月31日Return to NormalcyJuly 31, 2021, Portland, Oregon, USA: The spread of the Delta variant is claiming lives and threatening a return to normalcy in the United States. 605,780 Americans have died from the virus, more than the total number of Americans killed in World War I and World War II combined. The surging delta variant of COVID-19 makes up at least 88% of all cases in Oregon, according to Oregon Health and Sciences University Genome Sequencing Center. Health officials linked the increase to the more contagious delta variant, and reiterated unvaccinated people are most at risk. (Credit Image: © John Marshall Mantel/ZUMA Press Wire)、クレジット：©Ｊｏｈｎ Ｍａｒｓｈａｌｌ Ｍａｎｔｅｌ／ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021080405867
2021年07月31日Return to NormalcyJuly 31, 2021, Portland, Oregon, USA: The spread of the Delta variant is claiming lives and threatening a return to normalcy in the United States. 605,780 Americans have died from the virus, more than the total number of Americans killed in World War I and World War II combined. The surging delta variant of COVID-19 makes up at least 88% of all cases in Oregon, according to Oregon Health and Sciences University Genome Sequencing Center. Health officials linked the increase to the more contagious delta variant, and reiterated unvaccinated people are most at risk. (Credit Image: © John Marshall Mantel/ZUMA Press Wire)、クレジット：©Ｊｏｈｎ Ｍａｒｓｈａｌｌ Ｍａｎｔｅｌ／ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021080505434
2021年07月31日Return to NormalcyJuly 31, 2021, Portland, Oregon, USA: The spread of the Delta variant is claiming lives and threatening a return to normalcy in the United States. 605,780 Americans have died from the virus, more than the total number of Americans killed in World War I and World War II combined. The surging delta variant of COVID-19 makes up at least 88% of all cases in Oregon, according to Oregon Health and Sciences University Genome Sequencing Center. Health officials linked the increase to the more contagious delta variant, and reiterated unvaccinated people are most at risk. (Credit Image: © John Marshall Mantel/ZUMA Press Wire)、クレジット：©Ｊｏｈｎ Ｍａｒｓｈａｌｌ Ｍａｎｔｅｌ／ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021080505633
2021年07月31日Return to NormalcyJuly 31, 2021, Portland, Oregon, USA: The spread of the Delta variant is claiming lives and threatening a return to normalcy in the United States. 605,780 Americans have died from the virus, more than the total number of Americans killed in World War I and World War II combined. The surging delta variant of COVID-19 makes up at least 88% of all cases in Oregon, according to Oregon Health and Sciences University Genome Sequencing Center. Health officials linked the increase to the more contagious delta variant, and reiterated unvaccinated people are most at risk. (Credit Image: © John Marshall Mantel/ZUMA Press Wire)、クレジット：©Ｊｏｈｎ Ｍａｒｓｈａｌｌ Ｍａｎｔｅｌ／ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ／共同通信イメージズ
商品コード: 2021080403463
2021年08月01日Return to NormalcyAugust 1, 2021, Portland, Oregon, USA: The spread of the Delta variant is claiming lives and threatening a return to normalcy in the United States. 605,780 Americans have died from the virus, more than the total number of Americans killed in World War I and World War II combined. The surging delta variant of COVID-19 makes up at least 88% of all cases in Oregon, according to Oregon Health and Sciences University Genome Sequencing Center. Health officials linked the increase to the more contagious delta variant, and reiterated unvaccinated people are most at risk. (Credit Image: © John M. Mantel/ZUMA Press Wire Service)、クレジット：©Ｊｏｈｎ Ｍ． Ｍａｎｔｅｌ／ＺＵＭＡ Ｐｒｅｓｓ Ｗｉｒｅ Ｓｅｒｖｉｃｅ／共同通信イメージズ
商品コード: 2021080407889
- 1
- 2
- 3
- 4
